A number of other medications have proven helpful. Spironolactone, a diuretic, inhibits androgen production. Ketoconazole, an antifungal drug, also blocks the creation of male hormones. For women with minimal facial hair, there are a number of options, but all have drawbacks. Temporary solutions such as shaving and depilatories can provoke skin irritation.
Electrolysis is costly and uncomfortable, but it does yield results.
Laser therapy is similarly costly, and it should be used with caution by women with dark skin, since permanent skin blotching can occur. The most encouraging development is a cream called Vaniqu, that was submitted to the U.S. Food and Drug Administration for approval in October 1999. Vaniqu, which is manufactured by Bristol-Meyers Squibb and Gillette, is said to prevent hair growth with frequent use. Approval is expected sometime within the year 2000. All rights reserved.